TrialAIDS (London, England)2019

Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.

Tammy Meyers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.